scispace - formally typeset
H

Hongxia Zhao

Researcher at Guangdong University of Technology

Publications -  4
Citations -  312

Hongxia Zhao is an academic researcher from Guangdong University of Technology. The author has contributed to research in topics: Cancer & Internal medicine. The author has an hindex of 3, co-authored 3 publications receiving 171 citations. Previous affiliations of Hongxia Zhao include Jinan University.

Papers
More filters
Journal ArticleDOI

Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis

TL;DR: The structure and function of CD47 are described, an overview of studies that have aimed to inhibitCD47-dependent avoidance of macrophage-mediated phagocytosis by tumor cells are provided, and the potential and challenges for targeting the CD47-SIRPα signaling pathway in anti-cancer therapy are assessed.
Journal ArticleDOI

Detection of erythrocytes influenced by aging and type 2 diabetes using atomic force microscope

TL;DR: The aging- and diabetes-induced changes in morphological and biomechanical properties of erythrocytes are clearly characterized at nanometer scale using atomic force microscope (AFM) to potentially be developed into a powerful tool in diagnosing diseases.
Journal ArticleDOI

Photoinactivation effects of hematoporphyrin monomethyl ether on Gram-positive and -negative bacteria detected by atomic force microscopy.

TL;DR: The cytotoxic and phototoxic effects of hematoporphyrin monomethyl ether (HMME) on the Gram-positive and Gram-negative bacteria were investigated, and the results indicated that there was no significant cytotoxicity but high phototoxicity in the examined concentrations.
Journal ArticleDOI

Inhaled platelet vesicle-decoyed biomimetic nanoparticles attenuate inflammatory lung injury

TL;DR: Based on the inflammatory homing of platelets and cell membrane cloaking nanotechnology, in this paper , a biomimetic anti-inflammation nanoparticle delivery system for ALI treatment was developed by combining the poly (lactic-co-glycolic acid) nanoparticles (NPs) coated with platelet membrane vesicles (PM) for the purpose of highly targeting delivery of curcumin and resveratrol (RV) to inflammatory lungs.